Bhatt A; Khan S; Pandya KP; Sabri MI.
Effect of hexacarbons on selected lipids in developing rat brain and peripheral nerves.
Journal of applied toxicology : JAT
Iwasaki K; Tsuruta H.
Molecular mechanism of hexane neuropathy: significant differences in pharmacokinetics between 2.3-, 2.4-, and 2.5-hexanedione.
Politis MJ; Pellegrino RG; Spencer PS.
Ultrastructural studies of the dying-back process. V. Axonal neurofilaments accumulate at sites of 2,5-hexanedione application: evidence for nerve fibre dysfunction in experimental hexacarbon neuropathy.
Journal of neurocytology
[An experimental study on neurotoxicity of 2,5-hexanedione. Visual and somatosensory cortical evoked potentials in rats].
Sangyo igaku. Japanese journal of industrial health
DeCaprio AP; Olajos EJ; Weber P.
Covalent binding of a neurotoxic n-hexane metabolite: conversion of primary amines to substituted pyrrole adducts by 2,5-hexanedione.
Toxicology and applied pharmacology
Griffiths IR; Kelly PA; Carmichael S; McCulloch M; Waterston M.
The relationship of glucose utilization and morphological change in the visual system in hexacarbon neuropathy.
Narasimhan B; Judge V; Narang R; Ohlan R; Ohlan S.
Quantitative structure-activity relationship studies for prediction of antimicrobial activity of synthesized 2,4-hexadienoic acid derivatives.
Bioorganic & medicinal chemistry letters
Huchet G; Euerby MR; Mackay SP; Waigh RD.
The role of water in drug-receptor interactions.
Journal of enzyme inhibition and medicinal chemistry
Durham HD; Pe?a SD; Ecobichon DJ.
Hexahydrocarbon effects on intermediate filament organization in human fibroblasts.
Muscle & nerve
Ohno, H.; Tomioka, K., Science of Synthesis, (2008) 44, 117..
Science of Synthesis